Skip to main content
BARICADE Kurts
© Alessandro Winkler / UKB

News categories: Honors & Funding

Bacterial kidney infections in the focus of a new research group

The German Research Foundation (DFG) has approved funding of the new research unit “FOR 5427: Bacterial Renal InfeCtion And Defense (BARICADE)”

Infections of the kidney occur very frequently in the population and can have life-threatening consequences under certain circumstances. In order to better understand these bacterial infections at the molecular level, the German Research Foundation (DFG) is funding an interdisciplinary research group over the next four years. The spokesperson is Prof. Dr. Florian Wagenlehner, urologist at the Justus Liebig University Giessen (JLU). The project "Bacterial renal infections and their defense (BARICADE)" deals with bacterial virulence factors, host characteristics, especially the tissue-specific microenvironment and the innate immune response, as well as aspects of anti-bacterial therapy. The JLU, ImmunoSensation2 members at the University Hospital Bonn (UKB), the University of Duisburg-Essen and the Westfälische Wilhelms-Universität Münster collaborate in this group.

The urinary tract is frequently affected by bacterial infections, which not infrequently spread to the kidneys. Because of a variety of factors that reduce therapeutic success, this can have serious consequences. To make progress in this area and pave the way for new treatment strategies, the project is taking an interdisciplinary approach. "Our consortium consists of proven experts from various disciplines," explains Prof. Wagenlehner. His colleagues come from the fields of urology, nephrology (kidney medicine), microbiology and immunology and have joined forces to address important open questions together and with state-of-the-art technologies. The combination of different innovative approaches from the sub-disciplines creates added value for all individual projects by enabling them to answer questions that go beyond their own scope of research.

New methods for research into urinary tract infections


At the Institute of Molecular Medicine and Experimental Immunology (IMMEI) of the University Hospital Bonn (UKB), Dr. Selina Jorch aims to better understand the dynamics of the immune system in the context of human diseases. To better study the movement and function of individual immune cells in the kidney over time, Jorch uses a special microscopy technique: "With 2-photon microscopy, we can now directly observe how a special type of white blood cell called monocytes react to invading germs," says Jorch.

Also at IMMEI, Prof. Christian Kurts, PhD, focuses on the role of metabolism on infection. "We are interested in the influence of our high-salt and high-fat Western diet on our body's immune defenses against bacterial infection, " explains Prof. Kurts.

Prof. Dr. Sibylle von Vietinghoff is investigating the role and regulation of immune cells in the kidney in nephrology at the UKB's Medical Clinic I. "We want to investigate how modern diabetes drugs, which act on the kidney's sugar excretion, alter the ability of bacteria to attack the kidneys," explains Prof. von Vietinghoff.


Further information: https://www.dfg.de/service/presse/pressemitteilungen/2022/pressemitteilung_nr_51/index.html

Press contact:

Dr. Inka Väth
Medical Editor
Communications and Media Office at Bonn University Hospital
Phone: +49 228 287-10596
E-mail: inka.vaeth@ukbonn.de

Related news

Prof. Dr. Frank G. Holz – Director of the Department of Ophthalmology at the University Hospital Bonn (UKB) and Professor at the University of Bonn.

News categories: Honors & Funding

Frank Holz Nominated for the Science Breakthrough of the Year 2026

A remarkable achievement for the Faculty of Medicine at the University of Bonn: Prof. Dr. Frank G. Holz, Director of the Department of Ophthalmology at the UKB and Professor at the University of Bonn, has been shortlisted for the Falling Walls Science Breakthrough of the Year 2026 in the Life Sciences category. His project is now among the 30 most outstanding scientific innovations worldwide in this category, recognized by the prestigious Falling Walls Science Summit. Being shortlisted alone represents a significant international distinction.
View entry
Prof. Dr. Elvira Mass (left) and Prof. Dr. Tatjana Tchumatchenko (right)

News categories: Honors & Funding

Hunting for New Angles

New research questions often arise where different methods, mindsets and subject-specific cultures meet, and it is these kinds of encounter that Professor Elvira Mass and Professor Tatjana Tchumatchenko want to make happen in a targeted way in future. The two researchers have been picked as Henriette Herz Scouts by the Alexander von Humboldt Foundation.
View entry
Precise Konsortium

News categories: Publication Honors & Funding

Making Cancer Cells More Predictable: PRECISE Aims to Forecast Therapeutically Actionable Vulnerabilities

Which genes and signaling pathways does a cancer cell require to survive? And which of these could serve as therapeutic targets? The pan-European initiative PRECISE aims to identify such vulnerabilities not only through labor-intensive laboratory experiments but also by predicting them using computational models. The UKB and the University of Bonn, represented by Prof. Dr. Maximilian Billmann and Prof. Dr. Jonathan Schmid-Burgk, are among the founding partners of the consortium. The scientific vision of the initiative has now been published in a commentary in Nature Genetics.
View entry

Back to the news overview